Elevated Beta-Hydroxybutyrate: Clinical Significance and Interpretation

Diabetic Ketoacidosis

The American Diabetes Association recommends that beta-hydroxybutyrate (BHB) levels ≥1.5 mmol/L, when accompanied by hyperglycemia and acidosis, are diagnostic of diabetic ketoacidosis (DKA) 3, 4
DKA is characterized by the triad of hyperglycemia, increased blood ketones (particularly BHB), and metabolic acidosis with increased anion gap 2
The American Association of Clinical Endocrinologists suggests that caution is needed even with BHB levels ≥0.6 mmol/L in patients with diabetes, as this may indicate early ketosis 4, 5

BHB levels <0.6 mmol/L are considered normal range, while levels between 0.6-1.5 mmol/L indicate mild to moderate ketosis, requiring monitoring and possible intervention 4
BHB levels >1.5 mmol/L indicate significant ketosis, with a high risk for DKA when accompanied by hyperglycemia and acidosis 3

The American Academy of Pediatrics recommends that type 1 diabetes with insulin deficiency is a clinical scenario associated with elevated BHB 1, 2
The American Diabetes Association suggests that type 2 diabetes during severe illness or stress is also a clinical scenario associated with elevated BHB 2
Patients using SGLT2 inhibitors can develop DKA even with normal or only mildly elevated blood glucose, a condition known as "euglycemic DKA" 6

The American Diabetes Association recommends that BHB is superior to urine ketone testing for diagnosing and monitoring DKA 2
Blood ketone determinations that rely on the nitroprusside reaction should not be used to monitor DKA treatment as they don't quantify BHB specifically 2
Direct BHB measurement is recommended for diagnosing DKA in emergency settings, monitoring response to DKA treatment, and risk assessment in patients using SGLT2 inhibitors 2, 6

The American Diabetes Association suggests that in patients with type 1 diabetes, intense physical activity should be postponed when BHB ≥1.5 mmol/L due to risk of worsening ketosis 3, 4, 5

The American Association of Clinical Endocrinologists recommends that patients at risk for DKA should measure BHB when blood glucose is persistently elevated (>250 mg/dL), during illness, or when symptoms of ketosis appear 2, 3, 4, 6, 9